| scholarly article | Q13442814 |
| P50 | author | Carlo Agostini | Q43132912 |
| Gian Paolo Fadini | Q57544235 | ||
| Angelo Avogaro | Q87998934 | ||
| Marta Miorin | Q114320860 | ||
| Saula Vigili de Kreutzenberg | Q114320861 | ||
| Ilenia Baesso | Q114320867 | ||
| Mirko Menegolo | Q114320871 | ||
| P2093 | author name string | Monica Facco | |
| Franco Grego | |||
| Antonio Tiengo | |||
| Sondra Bonamico | |||
| P2860 | cites work | Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia | Q30760797 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1449-1457 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus | |
| P478 | volume | 45 |
| Q38156645 | A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications. |
| Q35055481 | AMP-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes |
| Q36885183 | AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ |
| Q43240676 | Abnormal cell responses and role of TNF-α in impaired diabetic wound healing |
| Q42931175 | Acceleration of Diabetic Wound Healing by Low-Dose Radiation is Associated with Peripheral Mobilization of Bone Marrow Stem Cells |
| Q36720543 | Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors |
| Q90479839 | Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications |
| Q37413615 | Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice |
| Q38169963 | Adiponectin as a tissue regenerating hormone: more than a metabolic function |
| Q37071934 | Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence |
| Q37275834 | Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells |
| Q37183949 | Aging and disease as modifiers of efficacy of cell therapy |
| Q81957665 | Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells |
| Q37536177 | Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia |
| Q41763265 | Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. |
| Q41986164 | Amlodipine Ameliorates Ischemia-Induced Neovascularization in Diabetic Rats through Endothelial Progenitor Cell Mobilization |
| Q34345679 | Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities |
| Q87128563 | An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model |
| Q37163068 | An underlying principle for the study of circulating progenitor cells in diabetes and its complications |
| Q35568131 | Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice |
| Q36837863 | Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing |
| Q40881340 | Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation |
| Q38312561 | Antihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice |
| Q46422748 | Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways |
| Q27312663 | Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration |
| Q36744812 | Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models |
| Q30430798 | Assessment of endothelial dysfunction in childhood obesity and clinical use. |
| Q38467521 | Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients |
| Q36824630 | Association of endothelial progenitor cells and peptic ulcer treatment in patients with type 2 diabetes mellitus |
| Q40260623 | Atherosclerotic plaque vulnerability in the statin era. |
| Q35168107 | Biology and flow cytometry of proangiogenic hematopoietic progenitors cells |
| Q36596218 | Biology of bone marrow-derived endothelial cell precursors |
| Q34576771 | Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients |
| Q37783801 | Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy |
| Q80676207 | Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment? |
| Q86077209 | Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment |
| Q64235754 | CD248: A therapeutic target in cancer and fibrotic diseases |
| Q92855414 | Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus? |
| Q38410742 | Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes |
| Q45916488 | Cause of death in infants of women with pregestational diabetes mellitus and the relationship with glycemic control. |
| Q38502595 | Cell Interactions with Vascular Regenerative MAA-Based Materials in the Context of Wound Healing |
| Q41813965 | Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity. |
| Q38627645 | Cell Therapy for Intracranial Aneurysms: A Review |
| Q37739010 | Cell-based methods for ex vivo evaluation of human endothelial biology. |
| Q35070554 | Cell-based therapies for diabetic complications |
| Q37879584 | Cell-based therapies for diabetic retinopathy |
| Q38044330 | Cell-specific insulin resistance: implications for atherosclerosis |
| Q41528907 | Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach |
| Q37859918 | Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets |
| Q33960253 | Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes |
| Q46208995 | Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies |
| Q26744760 | Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology |
| Q35742909 | Circulating CD133(+)VEGFR2 (+) and CD34 (+)VEGFR2 (+) cells and arterial function in patients with beta-thalassaemia major |
| Q43461095 | Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. |
| Q92212788 | Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes |
| Q37293820 | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence |
| Q35086811 | Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage |
| Q35415607 | Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes |
| Q41109188 | Circulating endothelial progenitor cells are not affected by acute systemic inflammation |
| Q37203258 | Circulating endothelial progenitor cells in cerebrovascular disease |
| Q39975065 | Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. |
| Q34640128 | Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome. |
| Q36302282 | Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study. |
| Q85157317 | Clinical Characteristics of Patients With Kawasaki Disease and Levels of Peripheral Endothelial Progenitor Cells and Blood Monocyte Subpopulations |
| Q37661456 | Clinical implication of endothelial progenitor cells |
| Q37875591 | Clinical science review article: understanding the implications of diabetes on the vascular system |
| Q41907027 | Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations |
| Q33550596 | Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control |
| Q38843000 | Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes. |
| Q102320360 | Concise review: current trends on applications of stem cells in diabetic nephropathy |
| Q36055443 | Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. |
| Q41248731 | Curcumin induces therapeutic angiogenesis in a diabetic mouse hindlimb ischemia model via modulating the function of endothelial progenitor cells |
| Q50101181 | Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study). |
| Q35879342 | Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes |
| Q30495462 | Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk |
| Q63285823 | Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats |
| Q37312527 | Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin |
| Q37156679 | Diabetes mellitus: an opportunity for therapy with stem cells? |
| Q41896798 | Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. |
| Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
| Q36644142 | Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics |
| Q51294899 | Diabetic Wound Healing In A MMP9-/- Mouse Model. |
| Q42031332 | Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha |
| Q48140973 | Diabetic polyneuropathy, deep white matter lesions, and carotid atherosclerosis: is there any association? |
| Q39477787 | Differences in the performance of PCL-based vascular grafts as abdominal aorta substitutes in healthy and diabetic rats |
| Q37131598 | Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia |
| Q27011819 | Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection |
| Q33410261 | Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells. |
| Q35222376 | Dysfunctional endothelial progenitor cells in metabolic syndrome |
| Q37699662 | EPCs and pathological angiogenesis: when good cells go bad. |
| Q36726184 | Early alterations of the immune transcriptome in cultured progenitor cells from obese African-American women |
| Q46437920 | Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial |
| Q43476236 | Effect of intensive glycaemic control on endothelial progenitor cells in patients with long-standing uncontrolled type 2 diabetes |
| Q42511510 | Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial. |
| Q36844897 | Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients |
| Q55397012 | Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke. |
| Q36157101 | Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study |
| Q34006386 | Effects of lycopene on number and function of human peripheral blood endothelial progenitor cells cultivated with high glucose |
| Q42849047 | Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients |
| Q53186699 | Effects of myocardial postconditioning on the recruitment of endothelial progenitor cells. |
| Q46222743 | Effects of nitric oxide on cell proliferation: novel insights |
| Q37684896 | Emerging roles of hematopoietic cells in the pathobiology of diabetic complications |
| Q39332638 | Endothelial Progenitor Cells for the Vascularization of Engineered Tissues |
| Q90455731 | Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk |
| Q90484553 | Endothelial Regenerative Capacity and Aging: Influence of Diet, Exercise and Obesity |
| Q33602535 | Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? |
| Q27011837 | Endothelial cells derived from nuclear reprogramming |
| Q37307167 | Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model. |
| Q37869700 | Endothelial dysfunction in diabetes: the role of reparatory mechanisms |
| Q36300017 | Endothelial function and its assessment |
| Q30433579 | Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy |
| Q36933858 | Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box? |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q35774189 | Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent |
| Q38001402 | Endothelial progenitor cells in diabetes mellitus. |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q40608911 | Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood |
| Q37362743 | Endothelial progenitor cells: markers of vascular reparative capacity |
| Q33705402 | Endothelial progenitor cells: therapeutic perspective for ischemic stroke |
| Q34433667 | Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits |
| Q33995043 | Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent |
| Q43077176 | Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix |
| Q28217721 | Enhanced spontaneous thrombolysis: a new therapeutic challenge |
| Q53779480 | Enumeration and functional investigation of endothelial progenitor cells in neovascularization of diabetic foot ulcer rats with a Chinese 2-herb formula. |
| Q93063997 | Ex vivo expansion of cord blood-derived endothelial cells using a novel xeno-free culture media |
| Q92313960 | Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018 |
| Q37418551 | From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. |
| Q35596594 | G-CSF protects human brain vascular endothelial cells injury induced by high glucose, free fatty acids and hypoxia through MAPK and Akt signaling |
| Q80735257 | Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes |
| Q41382687 | Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction |
| Q36739740 | Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway |
| Q48886329 | Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms |
| Q33789628 | Glucose challenge increases circulating progenitor cells in Asian Indian male subjects with normal glucose tolerance which is compromised in subjects with pre-diabetes: A pilot study |
| Q38105298 | Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells. |
| Q51469263 | Glucose tolerance is negatively associated with circulating progenitor cell levels. |
| Q90169679 | Glyoxalase 1 Prevents Chronic Hyperglycemia Induced Heart-Explant Derived Cell Dysfunction |
| Q59328968 | Green Tea Polyphenol Epigallocatechin-3-Gallate Promotes Reendothelialization in Carotid Artery of Diabetic Rabbits by Reactivating Akt/eNOS Pathway |
| Q90047347 | Growth hormone-releasing hormone promotes therapeutic effects of peripheral blood endothelial progenitor cells in ischemic repair |
| Q57767255 | HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia |
| Q35130773 | Habitual short sleep duration and circulating endothelial progenitor cells |
| Q38635396 | High glucose and free fatty acids induce endothelial progenitor cell senescence via PGC-1α/SIRT1 signaling pathway |
| Q38656088 | High glucose-induced endothelial progenitor cell dysfunction |
| Q52715775 | High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression. |
| Q33399716 | Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1. |
| Q39662200 | Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia |
| Q37715592 | Hydrogen sulfide improves wound healing via restoration of endothelial progenitor cell functions and activation of angiopoietin-1 in type 2 diabetes |
| Q36675614 | Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing |
| Q38112474 | Hyperbaric oxygen for chronic wounds |
| Q46264077 | Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions |
| Q55355643 | Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice. |
| Q37216686 | Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing |
| Q36137705 | Hypoxia-induced angiogenesis: good and evil |
| Q37694105 | Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling |
| Q36650615 | Identification of Biomarkers for Footpad Dermatitis Development and Wound Healing |
| Q47990239 | Identification of a restriction point at the M/G1 transition in CHO cells |
| Q33779819 | Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe |
| Q37202978 | Immune system in renal injury and repair: burning the candle from both ends? |
| Q42265318 | Impact of Trace Minerals on Wound Healing of Footpad Dermatitis in Broilers |
| Q64906873 | Impact of glycemic variability on the levels of endothelial progenitor cells in patients with type 1 diabetes. |
| Q27001633 | Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis |
| Q36274594 | Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease |
| Q84581891 | Impaired response of mature adipocytes of diabetic mice to hypoxia |
| Q48162025 | Importance and regulation of adult stem cell migration |
| Q35133453 | Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators |
| Q37045424 | Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients |
| Q35123614 | Induced pluripotent stem cells as a model for diabetes investigation |
| Q50925051 | Inflammation is associated with a reduced number of pro-angiogenic Tie-2 monocytes and endothelial progenitor cells in patients with critical limb ischemia. |
| Q90729475 | Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects |
| Q37598028 | Insulin signaling and life span. |
| Q58105024 | Intravenous human endothelial progenitor cell administration into aged mice enhances embryo development and oocyte quality by reducing inflammation, endoplasmic reticulum stress and apoptosis |
| Q37074243 | Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice |
| Q37172543 | Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model |
| Q55449346 | Loss of the Liver X Receptors Disrupts the Balance of Hematopoietic Populations, With Detrimental Effects on Endothelial Progenitor Cells. |
| Q37023956 | Low clonogenic potential of circulating angiogenic cells is associated with lower density of capillaries in skeletal muscle in patients with impaired glucose tolerance |
| Q34360080 | Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice |
| Q33698023 | Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia |
| Q33929661 | Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. |
| Q50985903 | Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus. |
| Q49243537 | Metformin accelerates wound healing in type 2 diabetic db/db mice |
| Q37209499 | Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study |
| Q37018236 | Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice |
| Q92819892 | MicroRNA-126 protects against vascular injury by promoting homing and maintaining stemness of late outgrowth endothelial progenitor cells |
| Q37905521 | Mobilization of stem and progenitor cells in cardiovascular diseases |
| Q54518388 | Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome. |
| Q37413067 | Molecular and clinical aspects of endothelial dysfunction in diabetes. |
| Q38599441 | Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder. |
| Q30459188 | Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. |
| Q34576158 | N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function |
| Q98280988 | NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function |
| Q37361572 | Negative-pressure wound therapy induces endothelial progenitor cell mobilization in diabetic patients with foot infection or skin defects. |
| Q37824119 | Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. |
| Q64096245 | Noninvasive Monitoring of Allogeneic Stem Cell Delivery with Dual-Modality Imaging-Visible Microcapsules in a Rabbit Model of Peripheral Arterial Disease |
| Q39719306 | Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome |
| Q37690105 | Obesity paradox in amputation risk among nonelderly diabetic men. |
| Q36953696 | Oxidative stress impairs endothelial progenitor cell function |
| Q37521530 | PPAR Gamma and Angiogenesis: Endothelial Cells Perspective. |
| Q34518904 | PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors. |
| Q35998796 | Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications. |
| Q36442393 | Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers |
| Q53545693 | Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. |
| Q48183918 | Periodontal treatment modulates gene expression of endothelial progenitor cells in diabetic patients. |
| Q37943863 | Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease |
| Q37269376 | Pharmacological approaches to improve endothelial repair mechanisms |
| Q34446306 | Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation |
| Q38219481 | Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus |
| Q36378007 | Prenatal Maternal Physical Activity and Stem Cells in Umbilical Cord Blood |
| Q30409726 | Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study |
| Q90655545 | Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes |
| Q64239396 | Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial |
| Q27002524 | Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes |
| Q26851313 | Redox regulation of stem/progenitor cells and bone marrow niche |
| Q33847880 | Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. |
| Q82468503 | Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity |
| Q37788983 | Regeneration of the vascular compartment |
| Q35195128 | Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner |
| Q37200278 | Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells |
| Q58730001 | Repeated Whole-Body Exposure to Low-Dose Radiation Combined With Topical Application of Basic Fibroblast Growth Factor and Zinc Accelerates Wound Healing in Diabetic Rats |
| Q51321906 | Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes. |
| Q35759361 | Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice |
| Q35073067 | Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers |
| Q33396460 | SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study |
| Q85649007 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34⁺CXCR4⁺ cells in patients with type 2 diabetes |
| Q39134052 | Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury |
| Q41954783 | Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction |
| Q39142796 | Stachydrine ameliorates high-glucose induced endothelial cell senescence and SIRT1 downregulation |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q41997705 | Stem cell therapy for the systemic right ventricle |
| Q38843402 | Stem cells and diabetic cardiomyopathy: from pathology to therapy |
| Q36446920 | Stem cells for the ischaemic heart |
| Q34137714 | Stepwise optimization of the procedure for assessment of circulating progenitor cells in patients with myocardial infarction. |
| Q33674663 | Substance P accelerates wound healing in type 2 diabetic mice through endothelial progenitor cell mobilization and Yes-associated protein activation |
| Q36861039 | Sun ginseng protects endothelial progenitor cells from senescence associated apoptosis |
| Q54996755 | TNFα contributes to diabetes impaired angiogenesis in fracture healing. |
| Q50929419 | Testosterone deficiency in male heart failure patients and its effect on endothelial progenitor cells. |
| Q39422921 | Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism |
| Q37421908 | The 9p21 myocardial infarction risk allele increases risk of peripheral artery disease in older people |
| Q92083723 | The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells |
| Q33822512 | The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature |
| Q91856541 | The Role of the Stem Cells Therapy in the Peripheral Artery Disease |
| Q41966633 | The contralateral extremity has also benefit from the locally administered bone marrow-derived mononuclear cells and cord blood serum in diabetic ischemic wound healing |
| Q38602992 | The diabetic foot in 2015: an overview |
| Q43734541 | The effect of diabetes mellitus and end-stage renal disease on the number of CD34+ cells in the blood. |
| Q33932817 | The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. |
| Q35808848 | The possible role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q35148886 | The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study |
| Q43063451 | The source of neointimal cells in vein grafts: does the origin matter? |
| Q26852080 | The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding |
| Q100385961 | Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study |
| Q40076736 | Therapeutic potential of novel modulators of neovascularization |
| Q36748161 | Therapy insight: diabetes and drug-eluting stents |
| Q54558264 | Thymosin β4 activates integrin-linked kinase and decreases endothelial progenitor cells apoptosis under serum deprivation. |
| Q58788889 | Thymosin β4 promotes glucose-impaired endothelial progenitor cell function via Akt/endothelial nitric oxide synthesis signaling pathway |
| Q33804692 | Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes |
| Q38022330 | Tissue engineering for the management of chronic wounds: current concepts and future perspectives |
| Q88647352 | Topical Application of Culture-Expanded CD34+ Umbilical Cord Blood Cells from Frozen Units Accelerates Healing of Diabetic Skin Wounds in Mice |
| Q34491057 | Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice |
| Q34024355 | Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions |
| Q37570669 | Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases |
| Q36138219 | Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. |
| Q52955938 | Umbilical Cord Blood Circulating Progenitor Cells and Endothelial Colony-Forming Cells Are Decreased in Preeclampsia. |
| Q34305712 | Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose. |
| Q64230394 | Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties |
| Q26772296 | Vascular Ageing and Exercise: Focus on Cellular Reparative Processes |
| Q40324178 | Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes |
| Q46168149 | Vascular dysfunction in patients with young β-thalassemia: relation to cardiovascular complications and subclinical atherosclerosis |
| Q26778658 | Vascular repair strategies in type 2 diabetes: novel insights |
| Q27026834 | Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise |
| Q40378041 | Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant Is Glycemic Control? |
| Q36384149 | Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies? |
| Q35145057 | Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K/Akt/eNOS pathway |
| Q51500477 | [Diabetes mellitus and coronary artery disease--a high risk combination]. |
| Q38056232 | mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases |
Search more.